Natco Pharma has appointed Amit Parekh as Executive Vice President – Finance and Accounts, effective December 2, 2025. This appointment is part of the company’s structured succession planning. Parekh will succeed S.V.V.N. Appa Rao as Chief Financial Officer at a board meeting scheduled for February 2026. Parekh brings over 20 years of experience to the role.
Executive Appointment
Amit Parekh has been appointed as the Executive Vice President – Finance and Accounts at Natco Pharma, effective December 2, 2025. This decision was approved by the Board of Directors via circular resolution on December 2, 2025.
Succession Plan
This appointment is part of Natco Pharma’s structured succession plan. Mr. Parekh will eventually succeed S.V.V.N. Appa Rao, the current Chief Financial Officer, during the board meeting to be held in February 2026, subject to necessary approvals.
Experience
Mr. Parekh brings more than 20 years of experience in managing financial and business affairs across various industries, including healthcare, pharmaceuticals, mining, engineering, telecommunications, and chemicals. His expertise includes CXO level engagements, investments, mergers and acquisitions, cost leadership projects, financial analysis, and risk assessment.
Prior to joining Natco Pharma, Mr. Parekh was Head of Finance – API and Pharmaceutical Services (PSAI) and Head of Digital Transformation in Finance at Dr. Reddy’s Laboratories Limited.
Source: BSE